Page 2 - ஜாக்கி டோர்ஸ்கி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜாக்கி டோர்ஸ்கி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜாக்கி டோர்ஸ்கி Today - Breaking & Trending Today

electroCore, Inc. Announces Agreement with Pro Medical Baltic to be Exclusive Distributor for ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
electroCore, Inc. Announces Agreement with Pro Medical Baltic to be Exclusive Distributor for .
electroCoreDecember 21, 2020 GMT
ROCKAWAY, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has entered into an agreement with Pro Medical Baltic UAB (“PMB”), whereby PMB will serve as the exclusive distributor of gammaCore Sapphire™ non-invasive vagus nerve stimulation (“nVNS”) to patients suffering from primary headache disorders in Lithuania, Latvia, Belarus, Kazakhstan and Ukraine.
“We are delighted to partner with Pro Medical Baltic to be able to introduce our nVNS therapy to new patients in Eastern Europe,” said Iain Strickland, electroCore’s Vice President of European Operations. “Pro Medical Baltic already has experience working with neuromodulation ....

United States , Jackie Dorsky , Hans Vitzthum , Iain Strickland , European Union , Core Inc , Pro Medical Baltic , Core Sapphire , Eastern Europe , Vice President , Medical Baltic , Cluster Headache , Trigeminal Autonomic Cephalalgias , Hemicrania Continua , Medication Overuse Headache , Core Instructions , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , ஜாக்கி டோர்ஸ்கி , இயேந் ஸ்ட்ரிக்லேண்ட் , ஐரோப்பிய தொழிற்சங்கம் , கோர் இன்க் , ப்ரொ மருத்துவ பால்டிக் , கோர் சபையர் , கிழக்கு யூரோப் , துணை ப்ரெஸிடெஂட் ,

electroCore Announces Positive Top-Line Results from PREMIUM II Migraine Prevention Study


electroCore Announces Positive Top-Line Results from PREMIUM II Migraine Prevention Study
December 08, 2020 08:00 ET
| Source:
electroCore
electroCore
Basking Ridge, New Jersey, UNITED STATES
BASKING RIDGE, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today top-line results from its GM-US-10 (PREMIUM II) study. Despite the early termination of the study in April 2020 due to the COVID-19 pandemic, all study endpoints, including several patient-assessed quality of life measures, showed benefit from non-invasive vagus nerve stimulation (nVNS), with many endpoints showing a statistically significant improvement with nVNS compared to sham stimulation.
In the predefined modified intent to treat population (mITT; n=113), which was the designated primary analysis population for the study, patients using gammaCore™ nVNS ha ....

United States , Jackie Dorsky , Hans Vitzthum , Eric Liebler , Virginia University Headache Center , European Union , Core Inc , Umer Najib , West Virginia University Headache Center , Cluster Headache , Trigeminal Autonomic Cephalalgias , Hemicrania Continua , Medication Overuse Headache , Core Instructions , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , ஜாக்கி டோர்ஸ்கி , வர்ஜீனியா பல்கலைக்கழகம் தலைவலி மையம் , ஐரோப்பிய தொழிற்சங்கம் , கோர் இன்க் , உமர் நஜிப் , மேற்கு வர்ஜீனியா பல்கலைக்கழகம் தலைவலி மையம் , கொத்து தலைவலி , மருந்து ஓவர்யூஸ் தலைவலி , கோர் வழிமுறைகள் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,